This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $960,076
Lattice Radiation Therapy versus Conventional Radiation Therapy for the Palliation of Large Tumors (LATTICE-PAL)
CIHR · 2026 · Co-investigator
- $1,071,000
The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer
CIHR · 2025 · Principal investigator
Lattice Radiation Therapy versus Conventional Radiation Therapy for the Palliation of Large Tumors (LATTICE-PAL)
Principal investigators: Lukovic, Jelena
Keywords: Palliative Care
The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer
Principal investigators: Bratman, Scott V; de Almeida, John R; Sanz Garcia, Enrique; Tsai, Chiaojung Jillian; Yao, Christopher M
Keywords: Adaptive Therapy; Ctdna; De-Escalation; Head And Neck Cancer; Hpv; Personalized Medicine; Radiotherapy; Surgery
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.